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Abstract
One of the major goals in large-scale genomic studies is to identify genes with
a prognostic impact on time-to-event outcomes which provide insight into the
disease’s process. With rapid developments in high-throughput genomic tech-
nologies in the past two decades, the scientific community is able to monitor the
expression levels of tens of thousands of genes and proteins resulting in enormous
data sets where the number of genomic features is far greater than the number of
subjects. Methods based on univariate Cox regression are often used to select ge-
nomic features related to survival outcome; however, the Cox model assumes pro-
portional hazards (PH), which is unlikely to hold for each feature. When applied
to genomic features exhibiting some form of non-proportional hazards (NPH),
these methods could lead to an under- or over-estimation of the effects. We pro-
pose a broad array of marginal screening techniques that aid in feature ranking
and selection by accommodating various forms of NPH. First, we develop an ap-
proach based on Kullback-Leibler information divergence and the Yang-Prentice
model that includes methods for the PH and proportional odds (PO) models as
special cases. Next, we propose R2 indices for the PH and PO models that can
be interpreted in terms of explained variation. Lastly, we propose a generalized
pseudo-R2 measure that includes PH, PO, crossing hazards and crossing odds
models as special cases and can be interpreted as the percentage of separability
between subjects experiencing the event and not experiencing the event according
to feature expression. We evaluate the performance of our measures using exten-
sive simulation studies and publicly available data sets in cancer genomics. We
demonstrate that the proposed methods successfully address the issue of NPH in
genomic feature selection and outperform existing methods. The proposed infor-
mation divergence, R2 and pseudo-R2 measures were implemented in R (www.R-
project.org) and code is available upon request.
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Abstract
One of the major goals in large-scale genomic studies is to identify genes with a prog-
nostic impact on time-to-event outcomes which provide insight into the disease’s pro-
cess. With rapid developments in high-throughput genomic technologies in the past two
decades, the scientific community is able to monitor the expression levels of tens of thou-
sands of genes and proteins resulting in enormous data sets where the number of ge-
nomic features is far greater than the number of subjects. Methods based on univariate
Cox regression are often used to select genomic features related to survival outcome;
however, the Cox model assumes proportional hazards (PH), which is unlikely to hold for
each feature. When applied to genomic features exhibiting some form of non-proportional
hazards (NPH), these methods could lead to an under- or over-estimation of the effects.
We propose a broad array of marginal screening techniques that aid in feature ranking
and selection by accommodating various forms of NPH. First, we develop an approach
based on Kullback-Leibler information divergence and the Yang-Prentice model that in-
cludes methods for the PH and proportional odds (PO) models as special cases. Next,
we propose R2 indices for the PH and PO models that can be interpreted in terms of ex-
plained variation. Lastly, we propose a generalized pseudo-R2 measure that includes PH,
PO, crossing hazards and crossing odds models as special cases and can be interpreted
as the percentage of separability between subjects experiencing the event and not expe-
riencing the event according to feature expression. We evaluate the performance of our
measures using extensive simulation studies and publicly available data sets in cancer
genomics. We demonstrate that the proposed methods successfully address the issue
of NPH in genomic feature selection and outperform existing methods. The proposed
information divergence, R2 and pseudo-R2 measures were implemented in R (www.R-
project.org) and code is available upon request.
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1 Introduction
There have been significant developments in high-throughput genomic and related tech-
nologies in the past two decades. Examples include microarray technology to mea-
sure mRNA and microRNA expression, methylation arrays to quantify DNA methylation,
SNP arrays to measure allele-specific expression and DNA copy number variation, next-
generation sequencing technologies such as RNA-Seq, ChIP-Seq, etc. for the measure-
ment of digital gene expression as well as mass spectroscopy and nuclear magnetic res-
onance spectroscopy for the measurement of protein and metabolite expression. With the
wealth of data available from large-scale genomic studies, researchers can now attempt
to understand and estimate the effects of specific genomic features on various diseases
and characteristics associated with those diseases. A genomic feature may represent a
gene that codes for a protein or a non-gene-centric element such as a microRNA, CpG
site or a particular genomic region of interest. One specific area of interest is in study-
ing the relationship between the expression of genomic features and time to death or
recurrence of some disease, often referred to as “survival time”. Let Y and C denote,
respectively, the survival and censoring times, and let δ = I(Y ≤ C) be the indicator of
whether the event has been observed. Because of censoring, it is not possible to observe
all true survival times, so we let T = min(Y,C) be the observed survival time. In this
study, we will deal with p features measured for each of n subjects, where p  n. We let
Z denote the n×p matrix of features and z represent the p-vector of features for a subject.
These high-dimensional data sets offer some explicit challenges when applying
standard statistical methods. One of the most commonly used models in survival analysis
is the Cox proportional hazards (PH) regression model (Cox, 1972) which postulates that
the risk (or hazard) of death of an individual, given their feature measurement, is simply
proportional to their baseline risk in the absence of the feature. It is a multiplicative haz-
ards model that implies constant hazard ratio (HR). In a high-throughput genomic study,
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for instance, the PH assumption would imply a constant effect of feature expression on
survival over the entire period of follow-up in a study. However, this assumption cannot be
verified for each feature and it is also unlikely that PH will actually hold for each feature.
Moreover, there is empirical evidence indicating that feature expression may not have a
multiplicative effect on the hazard and that non-proportional hazards (NPH) can occur
when feature effect increases or decreases over time leading to converging or diverging
hazards (CH or DH); in some studies, features with DH are found more often than fea-
tures with CH (Bhattacharjee et al., 2001; Xu et al., 2005; Dunkler et al., 2010; Rouam
et al., 2011). It is, therefore, unreasonable to expect the expression levels of the many
thousands of features to exhibit PH. In a review of survival analyses published in can-
cer journals, it was revealed that only 5% of all studies using the Cox PH model actually
checked the PH assumption (Altman et al., 1995). Applying the PH model to data that
do not support the underlying assumptions may result in inaccurate and sometimes er-
roneous conclusions. For instance, it could lead to under- or over-estimation of effects
for a considerable number of features. Consequently, some features are falsely declared
as important in predicting survival and other relevant features are completely missed.
Furthermore, if some features exhibit NPH then their HRs, estimated by ignoring their
time-dependence, are not comparable to those of features with PH or of features exhibit-
ing different patterns of NPH. Although NPH typically arises from time-dependent effects
of features on survival, it could also result from model mis-specification such as from
omitting relevant clinical covariates like age at diagnosis and stage of disease. Feature
selection methods involving univariate analyses are particularly prone to this problem.
The goal of this study is to discuss alternative models and methods that can be used
to link large-scale genomic data to a survival outcome, with the ultimate goal of feature
selection under different types of hazards that may be present.
This paper is organized as follows. In §2 we survey a variety of well known survival
models, many of which are designed to handle non-proportional hazards (NPH), and
3
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provide an overview of marginal screening methods that currently exist in the literature.
In §3, we use real-life genomic data to motivate the need for these models. Through
this analysis, we identify specific models that fit a large proportion of genomic features
and allow for NPH. Then in §4, we propose several feature selection methods that do not
rely on the PH assumption and, instead, are developed from models capable of handling
NPH. These methods are evaluated using extensive simulations and publicly available
large-scale data sets in cancer genomics in §5 and §6. Finally, §7 provides a summary
and some concluding remarks.
2 A brief survey of survival models and existing methods
2.1 The PH model and its generalization
The Cox PH model is a semi-parametric regression model proposed by Cox (1972). The
hazard rate, λ(t|z), is defined as the instantaneous risk of an event at time t for covariate
vector z, with Λ(t|z) representing the cumulative hazard function. The model is given by
λ(t|z) = λo(t) exp(β′z) and Λ(t|z) = Λo(t) exp(β′z), (2.1)
where t > 0, λo(t) and Λo(t) are the baseline hazard and cumulative hazards functions,
and β is a vector of regression coefficients. Estimation for the coefficient β can be done
by maximizing the log partial likelihood l(β) =
∑n
i=1 δi
{
z′iβ − log
[∑
j∈R(ti) exp(z
′
jβ)
]}
,
where ti is the survival time for subject i, δi is the censoring indicator, and R(ti) is the risk
set, the individuals who have yet to experience the event at time ti.
The hazard ratio corresponding to two different feature vectors z and z∗, given by
λ(t|z)
λ(t|z∗) = exp[β
′(z− z∗)], depends only on the features and not on time. This fundamental
assumption is unlikely to hold for all p features in the genomic setting. A semi-parametric
generalization of the Cox PH model which allows crossing hazards is described in De-
varajan & Ebrahimi (2011). In this model, the cumulative hazard and survival functions
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are, respectively,
Λ(t|z) = eβ′z{Λ0(t)}exp(γ′z) and S(t|z) = exp{−eβ′z[− logS0(t)]exp(γ′z)}. (2.2)
This model has a more flexible, general form, but retains the Cox PH model as a special
case when γ = 0. Since the partial likelihood approach cannot be applied, Devarajan &
Ebrahimi (2011) utilize a flexible parametric approach via a cubic B-spline approximation
for the baseline hazard to estimate the model parameters. Rouam et al. (2011) consid-
ered the special case obtained by setting β = 0 and proposed a pseudo-R2 measure for
genomic feature selection. In this paper, we refer to this special case as the crossing
hazards (CH) model.
2.2 The proportional odds (PO) model and its generalization
The PO model is an alternative to the PH model, and it does not require the assumption
of PH. It allows some forms of NPH and, instead, assumes that the effect of covariates
will proportionately increase or decrease the odds of dying or recurrence at time t. The
PO model is given by
1− S(t|z)
S(t|z) =
1− So(t)
So(t)
exp(β′z), (2.3)
where So(t) and ψ0(t) =
1−So(t)
So(t)
are the baseline survival and odds functions, respectively,
at time t. The multiplier exp(β′z) quantifies the amount of proportionate increase or de-
crease in the odds associated with covariate z. A semi-parametric generalization of the
PO model can be specified as
1− S(t|z)
S(t|z) =
[
1− S0(t)
S0(t)
]exp(γ′z)
exp(β′z), (2.4)
where γ = 0 results in the PO model. This model allows for both crossing hazards and
crossing odds. Later, we consider the special case where γ = β and refer to it as the
5
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crossing odds (CO) model.
2.3 Yang-Prentice (YP) model
Yang & Prentice (2005; 2012) proposed the YP model as a generalization of both the PH
and PO models. Its hazard and survival functions are given by
λ(t|z) = λ0(t) exp [(β + γ)
′z]
exp(β′z)− S0(t) exp(β′z) + S0(t) exp(γ ′z) (2.5)
and
S(t|z) =
(
S0(t) exp(γ
′z)
exp(β′z)− S0(t) exp(β′z) + S0(t) exp(γ ′z)
)exp(γ′z)
, (2.6)
respectively. Note that when γ = β, it becomes the PH model, and when γ = 0, it
becomes the PO model. Thus, it is a versatile and useful model that encompasses both
the PH and PO models, as well as a host of other models, and allows for time-varying
hazards. However, a practical limitation of this model is that inferential procedures are
available only for a single dichotomized covariate z.
2.4 Existing methods for feature selection
Few specific methods are currently available in the literature for the purpose of feature
selection when the PH assumption is violated. Dunkler et al. (2010) proposed concor-
dance regression, using a generalized concordance probability as a measure of the effect
size, to select genes in microarray studies that are related to survival irrespective of the
type of hazard. The basic concordance probability is c = P (T1 < T0), where T1 is a
randomly chosen survival time from group 1 and T0 is a randomly chosen survival time
from group 0, and is independent of the PH assumption. This is generalized to contin-
uous data which has the form c′ = exp(γ)
1+exp(γ)
, where γ are the log odds that the survival
time decreases if the gene expression is doubled. Then, c′ is modeled through its log
odds by P (Ti < Tj|xi > xj) = exp(xiγ)exp(xiγ)+exp(xjγ) , where the likelihood is computed as the
summation over all risk pairs (i, j) such that ti < tj and c′ is estimated by maximizing this
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likelihood. When ti is censored, it is not clear if ti < tj and appropriate weights are used
to account for the possible over-representation of some subjects (Schemper et al., 2009).
This model can be viewed as conditional logistic regression where the dependent variable
is the concordance of the risk pair (i, j). Genes are ranked based on the absolute effect
size cˆ′+ = .5+|cˆ′−.5|. Using simulated and microarray gene expression data Dunkler et al.
(2010) showed that when some of the genes showed a time-dependent effect on survival,
concordance regression produced the least biased and most stable estimates compared
to methods based on Cox regression. Rouam et al. (2010, 2011) developed pseudo-R2
measures for genomic feature selection based on the PH and CH models which rely on
the partial likelihood of the respective model and utilizes the score statistic.
3 Motivating examples
We motivate our problem using five data sets from large-scale studies in cancer utilizing
a variety of high-throughput genomic technologies. Data sets 1 and 2 consist of DNA
methylation and microRNA expression profiles, respectively, measured on glioblastoma
samples while data set 3 consists of digital gene expression profiles obtained using RNA
sequencing from subjects with head and neck squamous cell carcinoma (The Cancer
Genome Atlas (TCGA), http://cancergenome.nih.gov). Data sets 4 and 5 consist of gene
expression data obtained using Affymetrix and HG 1.ST microarrays, respectively, from
patients with ovarian and oral cancer (Tothill et al, 2008; Saintigny et al, 2011). Raw data
was pre-processed using standard methods for each data set as described in the Supple-
mentary Information (SI): Data Sets and Implementation (§8). Relevant characteristics of
these data sets are outlined in Tables 1 & 2. In what follows, we describe a comprehensive
analysis of these data sets using the PH, PO and YP models to test for the goodness-of-fit
(GOF) of each model using the methods outlined in Grambsch & Therneau (1994), Mar-
tinussen & Scheike (2006) and Yang & Prentice (2012), respectively. All analyses were
performed at the genomic feature level, the purpose of which is to identify features that
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exhibit some form of NPH and to demonstrate the need for alternatives to the PH model.
Wherever possible, clinical covariates such as age at diagnosis and stage of cancer were
adjusted for in the analysis (data sets 3-5, Table 1). The currently available method for the
YP model is only capable of handling a single dichotomized covariate (Yang & Prentice,
2005; 2012), and, hence, we utilized dichotomized expression of genomic features and
did not adjust for age and stage in analyses reported in Table 2. This enabled direct com-
parison of results from different models. The q-value approach was employed to estimate
the false discovery rate (FDR) and to evaluate the effect of testing multiple hypotheses
(Storey & Tibshirani, 2003). In summary, GOF results based on continuous expression
for the PH and PO models (data sets 1-5) as well as dichotomized expression for the PH,
PO and YP models (data sets 1, 2 & 4) are presented in Tables 1 and 2, respectively.
Use of continuous expression - typically on a variance stabilized and normalized
scale that depends on the data type of the genomic feature - offers a comprehensive
approach to our problem and can be used to compute all the R2-type and information
divergence measures developed in this work. It facilitates a straightforward interpretation
of the hazard ratio as the fold-change in hazard that corresponds to a unit change in ex-
pression on the transformed scale; however, currently it cannot be used for estimation
in the YP model and for visualization. On the other hand, dichotomized expression of
genomic features - particularly gene expression - is commonly used in real-life applica-
tions as evidenced by the literature in high-throughput genomic data analyses (Dunkler
et al., 2010; Rouam et al, 2011; Peri et al., 2013). In this approach, the expression of
each feature is typically categorized as a “high” or “low” value for each subject based on
the median split. Although imperfect, it enables graphical summary of the results in the
form of Kaplan-Meier survival curves for subjects with “high” and “low” expression where
the hazard ratio is interpreted as the fold-change in hazard between the “low” and “high”
expression groups. It can be used for all three models of interest in our problem; however,
it is applicable only to information divergence measures.
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In Tables 1 and 2, we employ the following abbreviations: Subset A represents
genomic features for which the PH model does not fit; B and C refer to subsets of features
for which the PO and YP models fit, respectively; and B’ refers to the subset for which the
PO model does not fit. As seen from Table 1, the FDR is controlled at an acceptable level
(q-value ≤ 0.25) in nearly all analyses involving continuous expression. Overall, the PO
model is observed to fit a large fraction of genomic features across all data sets (85-92%,
subset B). There is clear evidence that the PH model does not fit a significant number
of features in these data sets, particularly 2, 4 & 5, where the actual number itself varies
across these sets (14-29%, subset A). However, it is important to note that for a majority
of the features in these subsets the PO model provides a good fit (52-65%, subset A ∩
B), thereby making this model an attractive alternative to the PH model when continuous
expression is considered and potential confounders need to be accounted for. The results
for data sets 3, 4 & 5 are further strengthened by an adjustment for confounders such as
age at diagnosis and stage of disease. Although the PH model is seen to provide a good
fit to most features in data set 1, it is interesting to note that the PO model fits 78% of
features (170 out of 217) for which the PH model does not fit. Thus, it would be beneficial
to develop methods based on the PO model because it has been shown to handle NPH
(Martinussen & Scheike, 2006). In each data set, there exists a reasonable number of
features for which neither the PH nor the PO model fits (subset A ∩ B’). This subset
contains a median 35% of features for which the PH model does not fit and, in particular,
for data set 3 it represents 62% of features (464 out of 752). These observations suggest
the need for a more general survival model such as the YP.
As noted earlier, the YP model cannot be used on continuous expression due to
current limitation in methods. However, as shown in Table 2, when applied to dichotomized
expression the YP model provides a good fit to a majority of the features in each data set
considered (92-97%, subset C). This is not surprising given the flexible form of the YP
model and its inclusion of the PH and PO models as special cases. More importantly, the
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PO model is observed to fit a large fraction of genomic features across all data sets (91-
94%, subset B). In each data set, the PH model does not fit a large number of features
(10-18%, subset A). Once again, the PO model provides a good fit for an overwhelming
fraction of features for which PH does not fit - 91%, 88% and 69%, respectively, for data
sets 1, 2 and & 4 as shown in Table 2 (subset A ∩ B). In addition, the YP model provides
a good fit to an even larger fraction of features for which the PH does not fit - 95%, 98%
and 91%, respectively, for these data sets (subset A ∩ C). Furthermore, the YP model
serves as a useful alternative for genomic features for which both the PH and PO models
do not provide a good fit. In our examples, the YP model provides a good fit for 89-94%
of genomic features for which neither PH nor PO fits (subset A ∩ B’ ∩ C). Thus, the YP
model shows versatility and the ability to fit a large number of features when the PH and
PO models do not. The PO and YP models, therefore, provide flexible alternatives to the
PH model when dichotomized expression is considered and it would be useful to develop
methods based on these models for handling various forms of NPH. In summary, these
results serve as motivation for developing methods based on the PO and YP models
because of their ability to fit not only a large number of genomic features in general, but
specifically features for which the PH assumption is violated.
Table 1: Summary of model fits: continuous data
Data set 1 2 3 4 5
p 9,452 454 19,341 24,739 12,776
n 280 416 221 276 86
% Censored 26% 19% 62% 32% 59%
A: PH (lack of fit) 217 (2%)c 130 (29%)b 752 (4%)a 3,881 (16%)b 1,810 (14%)b
B: PO (good fit) 8,708 (92%)b 385 (85%)b 17,349 (90%)b 22,424 (91%)b 11,544 (90%)b
A ∩ B 170 85 288 2,513 947
A ∩ B’ 47 45 464 1,368 863
p: Number of features; n: Number of observations; q-value: 0.99a;≤ 0.25b;≈ 0.5c
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Table 2: Summary of model fits: dichotomized data
Data set 1 2 4
p 9,452 454 24,739
n 280 416 276
% Censored 26% 19% 32%
A: PH (lack of fit) 941 (10%)b 82 (18%)b 3,366 (14%)b
B: PO (good fit) 8,880 (94%)c 426 (94%)b 22,628 (91%)c
C: YP (good fit) 9,038 (96%)c 441 (97%)a 22,796 (92%)c
A ∩ B 854 72 2,325
A ∩ C 896 80 3,051
A ∩ B’ (∩ C) 87 (82) 10 (9) 1,041 (926)
p: Number of features; n: Number of observations; q-value: 0.99a;≤ 0.26b; 0.33-0.53c
4 Proposed methods for feature selection and ranking
In §3, we demonstrated the need for alternative methods to the PH model that can handle
various types of NPH. We also showed in Tables 1 and 2 that there are many features for
which the PH model does not fit but the PO or YP model does; and for some features,
we observed that both the PH and PO models do not fit thereby suggesting the need for
more complex models such as the YP or CO.
In this section, we construct several marginal screening approaches based on the
PO, CO and YP models. First, we adopt an information-theoretic approach and develop a
test for genomic feature effect under the YP model using Kullback-Leibler (KL) information
divergence. This approach includes tests as well as R2 measures for its two important
special cases - the PO and PH models. Following this, we propose a unified framework
to compute pseudo-R2 measures for a wide range of survival models that allow different
types of NPH. It includes the PH, CH, PO and CO models and generalizes prior work
(Rouam et al., 2010; 2011). Finally, we propose R2 measures for the PO model based on
11
Hosted by The Berkeley Electronic Press
the likelihood ratio. The utility of these new marginal screening methods is demonstrated
using simulated and real-life genomic data sets and by comparison to existing methods.
4.1 Methods based on information divergence
4.1.1 Test for genomic feature effect under the YP model
Within the framework of the YP model, we would like to test the null hypothesis H0 :
Λ(t|z) = Λ0(t) against the alternative H1 : Λ(t|z) =
t∫
0
λ(t|z)dt, where λ(t|z) is as specified
in equation (2.5). These hypotheses can be rewritten as H0 : β = 0, γ = 0 vs. H1 : β 6=
0, γ 6= 0, i.e., we are interested in testing whether a particular genomic feature has an
effect on survival time according to the YP model. To this end, we utilize KL information
divergence and construct a test statistic. Let f0(t) and f(t|z) denote the densities of
T under H0 and H1, respectively, and let F0 and F be the corresponding distribution
functions. Then KL information divergence is defined as
I(F0 : F |z) =
∞∫
0
f0(t) log
{
f0(t)
f(t|z)
}
dt, (4.1)
and is the directed divergence that measures the discrepancy between F0 and F . Equa-
tion (4.1) quantifies the divergence between the null and alternative hypotheses and can
be viewed as a weighted log-likelihood ratio, i.e., I(F0 : F ) = Ef0
(
log
{
f0(t)
f(t|z)
})
. We will
use this quantity to develop a test for genomic feature effect.
Under the YP model in equations (2.5) and (2.6), we have f(t|z) = λ(t|z)S(t|z)
and f0(t) = λ0(t)S0(t). Hence, feature-specific KL information divergence for the YP
model has the form
IY P (F0 : F |z) =
∞∫
0
f0(t) log
{
λ0(t)S0(t)
λ(t|z)S(t|z)
}
dt =
exp(βz) [βz exp(γz)− γz − 2]− exp(γz) [γz exp(βz)− βz − 2]
exp(βz)− exp(γz) .
(4.2)
Let zij represent the expression for individual i and feature j, where i = 1, . . . , n and
j = 1, . . . , p. We estimate this measure by replacing β and γ with βˆ and γˆ, the pseudo
12
https://biostats.bepress.com/cobra/art120
maximum likelihood estimates obtained using the approach in Yang & Prentice (2005;
2012), and by summing over the n individuals in a study. Thus, we obtain the following
estimate of IjY P for feature j
IˆjY P =
n∑
i=1
exp(βˆzij)
[
βˆzij exp(γˆzij)− γˆzij − 2
]
− exp(γˆzij)
[
γˆzij exp(βˆzij)− βˆzij − 2
]
exp(βˆzij)− exp(γˆzij)
. (4.3)
From Theorem 1 (see SI: Methods, §9.1) it can be seen that IˆY P is a maximum likelihood
estimator and is asymptotically normal with mean IY P . Despite the complexity of the YP
model, IˆY P has the computational advantage of not requiring an estimate of the baseline.
In addition, it combines feature effects quantified by the two model parameters β and γ
into a single measure and provides a simpler interpretation of feature effect. However,
a practical limitation of the currently available estimation method for this model is that it
requires dichotomized feature expression (Yang & Prentice, 2005; 2012). Therefore, we
propose IY P as a measure for ranking feature effect. In our applications, IY P was esti-
mated using βˆ and γˆ obtained by fitting the YP model to feature expression dichotomized
by the median. Details on the derivation of IY P are provided in SI: Methods (§9.1).
4.1.2 Tests for genomic feature effect under the PO and PH models
As outlined earlier, the YP model contains the PO and PH models as special cases. In
equations (2.5) and (2.6), setting γ = β results in the PH model and setting γ = 0 results
in the PO model. In each model there is a single parameter β and we are interested
evaluating feature effect under the respective model by testing the null hypothesis H0 :
β = 0 against the alternative H1 : β 6= 0.
The test statistic for feature j under the PO model is obtained by setting γ = 0 in
equation (4.2) and using equation (4.3) which simplifies to
IˆjPO =
n∑
i=1
βˆzij exp(βˆzij)− 2 exp(βˆzij) + βˆzij + 2
exp(βˆzij)− 1
, (4.4)
13
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where βˆ is the modified partial likelihood estimator (Martinussen & Scheike, 2006). From
Theorem 2 (see SI: Methods, §9.1, for details on IPO), it can be seen that IˆPO is a max-
imum likelihood estimator and is asymptotically normal with mean IPO. The variance of
IˆPO can be estimated using the delta method and Taylor series expansion as
Var(IˆPO) ≈
n∑
i=1
n∑
i′=1
1
18
z2i z
2
i′σ
4, (4.5)
where σ is the variance under H0. Details on the derivation of V ar(IˆPO) are provided in
SI: Methods (§9.1). Using (4.5) we can reject H0 if
χˆ2PO =
Iˆ2PO
ˆV ar(IˆPO)
> χ21. (4.6)
The test statistic for feature j under the PH model, IˆPH , is obtained by setting γ = β in
equation (4.3) resulting in a test similar to those outlined above for the YP and PO models.
This is outlined in Devarajan & Ebrahimi (2009); however, it has not been applied to large-
scale genomic data and could potentially over- or under-estimate feature effects when the
PH assumption is violated. In that regard, the proposed methods based on YP and PO
models benefit from the simplicity of this approach while addressing the issue of NPH.
4.1.3 Feature ranking and selection
Since Iˆ quantifies the effect of a genomic feature according to the particular model of
interest, it can be directly used to serve as a measure for feature ranking. Both IˆPO and
IˆY P can be calculated for each feature in a data set where a higher Iˆ indicates a larger
effect on survival based on the particular model chosen. Similarly, the test statistic in
equation (4.6) based on the PO model can be used to to compute a p-value for each
feature and features can be selected by controlling the FDR, at a pre-determined level
such as 5%, using the Benjamini-Hochberg approach (Benjamini & Hochberg, 1995). A
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similar approach can be used for feature selection and ranking using IˆPH under the PH
model. It is straightforward to account for potential confounders (such as age and stage
of disease) by utilizing the model parameter estimate from the adjusted model in the
computation of IˆPO and IˆPH and their respective test statistics. Moreover, standard GOF
tests such as those used in §3 can be used to determine which of the three measures to
use.
4.2 Measures of explained variation
4.2.1 R2 measures based on information divergence
We utilize tests for genomic feature effect proposed in §4.1.2 to develop R2 measures,
that quantify the fraction of variation explained, for the PO and PH models. These indices
take values on the [0, 1] scale and are easy to interpret. From equation (4.2), feature-
specific KL information divergence for the PO model can be obtained by setting γ = 0 and
expressed as
IPO(F0 : F |z) = βz exp(βz)− 2 exp(βz) + βz + 2
exp(βz)− 1 = βz − 2 +
2βz
exp(βz)− 1 , (4.7)
where z represents feature expression. Similarly, feature-specific KL information diver-
gence for the PH model can be written as
IPH(F0 : F |z) = exp(βz)− βz − 1. (4.8)
which is obtained in the limit as β → γ in equation (4.2). In §4.1.1 and §4.1.2, we de-
rived tests for feature effect in the YP and PO models using the respective Iˆ by summing
over n individuals in a data set. This approach accounts for the feature expression of
each individual in the study. Here we propose an alternative, but more robust, approach
by integrating over the covariate distribution; in this case, the distribution of feature ex-
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pression. A normalizing transformation stabilizes the variance and can be applied to a
variety of large-scale genomic data for this purpose. Examples include the logarithmic
transformation for mRNA and miRNA gene expression, the log(x + 1) transformation for
digital gene expression and the logit transformation for DNA methylation while copy num-
ber variation is expressed as log-ratios. In addition, if we standardize the expression of
each feature to have zero mean and unit standard deviation, then Z ≡ zij iid∼ Normal(0, 1),
where i = 1, . . . , n and j = 1, . . . , p. We define I˜ as the expectation of I(F0 : F ) with
respect to the marginal distribution of Z,
I˜ = EZ [I(F0 : F )] =
∫ ∞
−∞
I(F0 : F |z)φZ(z)dz, (4.9)
where φZ(z) is the standard normal density. I˜ is computed for the PO and PH models
using I(F0 : F |z) in equations (4.7) and (4.8), respectively. An R2 is then defined as
R2
I˜
= 1− exp(−2I˜) (4.10)
(Joe, 1989; Soofi et al., 1995). For the PO model, I˜PO is calculated using Taylor series
expansion as
I˜PO =
∫ ∞
−∞
IPO(β; z)φZ(z)dz ≈ 1
6
β2, (4.11)
and, hence,
R2
I˜PO
= 1− exp(−2I˜PO) = 1− exp(−1
3
β2), (4.12)
where β is replaced by βˆ, the modified partial likelihood estimator in the PO model ob-
tained using standardized feature expression (Martiussen & Scheike, 2006). For the PH
model, we calculate I˜ directly using IPH as
I˜PH =
∫ ∞
−∞
IPH(β; z)φZ(z)dz = exp
(
1
2
β2
)
− 1. (4.13)
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Hence,
R2
I˜PH
= 1− exp(−2I˜PH), (4.14)
where β in I˜PH is replaced by βˆ, the partial likelihood estimator parameter in the PH model
obtained using standardized feature expression (Cox, 1972). Details regarding the deriva-
tion of I˜PO and I˜PH are provided in SI: Methods (§9.2). Both R2I˜PO and R
2
I˜PH
can be easily
seen to fall in the [0, 1] range and can be used for feature ranking and selection where
genomic features with larger R2 values can be interpreted as exhibiting larger effects
on survival under the respective models. These measures have an information-theoretic
foundation and are easy to compute; from equations (4.11) and (4.13), we observe that
both measures are simple functions of the respective model parameter β which contains
the required information if feature expression can be normalized to follow the standard
normal model.
4.2.2 R2 measures based on the likelihood ratio
We propose three different R2 measures for the PO model based on likelihood ratio (LR),
log L(βˆ)
L(0)
, where L(0) and L(βˆ) denote the modified partial likelihood for this model under
the null and alternative hypotheses, respectively, and the parameter β is estimated using
the approach outlined in Martinussen & Scheike (2006) (see SI Methods, §9.3, for the
modified partial likelihood). These measures parallel corresponding R2 measures for the
PH model that exist in the literature and can be interpreted as the proportion of variation
explained by the PO model (Allison, 1995; Nagelkerke, 1991; O’Quigley et al., 2005). The
first measure is based on Allison’s index (Allison, 1995) which uses a transformation of
the log partial likelihood ratio. It has the form R2LR,A = 1 − exp
(
− 2
N
[
log L(βˆ)
L(0)
])
where N
is the number of subjects. The second measure is a modified version of Allison’s index
based on the work in O’Quigley et al. (2005) where N in R2LR,A is replaced by k, the
number of failures. It is less sensitive to censoring which is beneficial in our application
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due to the observed high fraction of censored observations in large-scale genomic data
sets. It is given by
R2LR,O = 1− exp
(
−2
k
[
log
L(βˆ)
L(0)
])
. (4.15)
The last measure is based on Nagelkerke’s index (Nagelkerke, 1991) and is another mod-
ified version of Allison’s index obtained by dividing the index by its maximum possible
value. It has the form R2LR,N =
R2LR,A
R2max
where R2max = 1 − exp
(
2
N
logL(0)
)
. While these
measures result in different values and ranges for a specified data set, we note from em-
pirical observation that their rankings are the same. In our simulated study, we found that
although their values differed, R2LR,A, R2LR,O, and R2LR,N resulted in the same feature rank-
ings. Hence, we choose to use R2LR,O for the remainder of the analysis. For simplicity of
notation, we will refer to R2LR,O as R2LR going forward.
4.3 A generalized pseudo-R2 measure
We develop pseudo-R2 measures for the PO and CO models, denoted by R2PO and R2CO,
as well as a generalized pseudo-R2 measure that embeds such measures for the PH,
CH, PO and CO models. The proposed approach utilizes the partial likelihood of the
respective models and does not require an estimate of the parameter β in these models.
It generalizes the work of Rouam et al. (2010, 2011) where measures for the PH and CH
models, which we denote by R2PH and R2CH , respectively, were proposed. These pseudo-
R2 measures can be interpreted in terms of the difference in the expression of a genomic
feature between subjects experiencing and not experiencing the event of interest, and can
be used as tools for feature ranking and selection under a variety of scenarios involving
NPH. An obvious disadvantage of R2PH is that it is based on the PH model. In the CH
model, the hazard ratio between two individuals with feature expression z and z∗ cross
over time (Rouam et al., 2011). Thus, while R2CH does address the inherent problem with
R2PH , it forces crossing hazards. Therefore, the measure itself is specifically designed
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to identify crossing hazards. The advantage of the PO model is that it can handle non-
proportional hazards while still allowing for proportional hazards, and therefore, is more
generally applicable to the variety of hazard structures observed in genomic data. This
is evidenced by the results shown in Tables 1 and 2 where PO fits features that exhibit
both PH and some forms of NPH. The CO model generalizes the PO model in the same
manner as the CH model generalizes the PH model and, thus, has a more versatile form.
For our purposes, we will use the special case γ = β in equation (2.4). Hence, the
measures R2PO and R2CO based on these models offer significant advantages and flexibility
that is not afforded by currently available measures.
The generalized pseudo-R2 index can then be expressed as
R2 =
1
k
(
n∑
i=1
Wˆi
)2
n∑
i=1
Wˆ 2i
, (4.16)
where Wˆi = δiwˆ(ti)
zi −
n∑
j=1
Yj(ti)zj
n∑
j=1
Yj(ti)
− n∑
j=1
δjwˆ(tj)Yi(tj)
n∑
r=1
Yr(tj)
zi − n∑r=1Yr(tj)zrn∑
r=1
Yr(tj)
, zi is the expression
of a given feature for subject i, k is the number of uncensored failure times and Y¯ =
n∑
j=1
Yj
is the number of subjects at risk at time ti (see SI: Methods, §9.3, for details). This index
can be seen as the robust score statistic divided by the number of distinct uncensored
failure times, a quantity that falls between 0 and 1 and can be interpreted in terms of
the percentage of separability between subjects experiencing and not experiencing the
event in relation to the expression of a genomic feature. Using equation (4.16), indices
corresponding to the PH, CH, PO and CO models based on model-specific choice of
the weight, w(t), determined by the respective partial likelihood can be obtained (see SI:
Methods, §9.3, for a derivation of weights). The estimated weight, wˆ(t), for each special
case is shown in Table 3 and can be interpreted as the derivative of the log hazard ratio
for the corresponding model with respect to the parameter β evaluated at β = 0. In
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Table 3, Λ0(t) is estimated by the left-continuous version of Nelson’s estimator and S0(t)
is estimated using the Kaplan-Meier (KM) estimator. We note that R2PH and R2CH are the
measures described in Rouam et al. (2010, 2011) while R2PO and R2CO are our newly
proposed measures that allow for various types of NPH as well as PH. In order to avoid
numerical issues, we applied empirical corrections in the computation of R2CH and R2CO
(see SI: Methods, §9.3, for details).
Table 3: Pseudo R2: Special Cases
Model Measure Weight function, wˆ(t)
PH R2PH 1
CH R2CH 1 + log{Λˆ0(t)}
PO R2PO Sˆ0(t)
CO R2CO 1 + Sˆ0(t)− Sˆ0(t) log
(
Sˆ0(t)
1−Sˆ0(t)
)
5 Application to simulated data
In this section, we evaluate our newly proposed ranking methods, IPO, IY P , R2I˜PO , R
2
I˜PH
,
R2PO, R2CO, R2ModCH and R
2
LR using simulated data sets under a variety of scenarios and
compare their performance to existing methods, R2PH , R2CH and cˆ′+ (Rouam et al., 2010,
2011; Dunkler et al., 2010). The goal of this study is to assess the performance of
these methods in selecting features that are truly associated with survival in the high-
dimensional setting.
5.1 Simulation schemes
We considered two different simulation schemes to generate artificial survival and ge-
nomic data sets based on the approach outlined in Dunkler et al. (2010). In order to
account for various types of hazards, survival times Yi, i = 1, . . . , n, were generated from
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each of 5 different models specified as follows: standard log-normal LN (µ = 0, σ = 1);
log-logistic LL1 (α1 = 2, λ1 = 2, λ2 = 4) and LL2 (α1 = 3, α2 = 4, λ1 = 1, λ2 = 2); and
Weibull W1 (α1 = 1, λ1 = 12 ) and W2 (α1 = 3, α2 = 2, λ1 = 1, λ2 =
1
2
), where LL1 and W1
refer to the respective models where the shape parameters are the same but the scale
parameters differ, and LL2 and W2 refer to the respective models where both the shape
and scale parameters differ. In the LN model, µ and σ are the location and scale parame-
ters, respectively. We use a more informed approach that is broader in scope compared
to that of Dunkler et al. (2010), who only considered W1 in their simulations. Here, LN,
LL2 and W2 cases are of particular interest because of their ability to simulate crossing
hazards. To simulate censoring, we drew random samples with uniform follow-up times
C from U(0, τ) and defined the observed survival time as T = min(Y,C) with censoring
indicator δ = I(T = Y ). We chose τ to get censoring proportions of 0, 33, and 67%.
For each model, we simulated censored survival times and genomic data for N =
200 subjects and p = 5000 mock features whose expression is linked to survival time
based on the logarithm of the hazard ratio (HR), βg(t) = β0 log(HR). Genomic data was
generated from the standard normal model which covers a variety of features seen in
large-scale genomic studies. Following Klein and Moeschberger (2003), log(HR) was
calculated based on the respective model of interest. For LN, we used βg(t) = β0(t2 − 1)
to simulate crossing hazards similar to what was done in Dunkler et al. (2010). Then, β0
was chosen so that only the first 400 features were assumed to have an effect on survival
time, with 200 having a large effect and 200 having a small effect. In Scheme 1, we
adopt a univariate approach where the expression of each feature is separately linked to
survival, and in Scheme 2 we adopt a multivariate approach that incorporates correlations
between features. More details on these steps can be found in Dunkler et al. (2010).
For each simulation scheme and censoring combination, 200 data sets were gen-
erated and assessed. The ranking methods developed §4 were applied to each data set
and genomic features were ranked based on each method. The results are summarized
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using mean AUC, specificity, sensitivity and the Youden index (Youden, 1950) across the
200 simulations in each case and used to compare the methods. The Youden index is
calculated as J = sensitivity + specificity − 1 where higher values are desirable.
5.2 Simulation Results
Overall, under different models (LN, LL1, LL2, W1, W2) and censoring proportions (0,
33, 67%), the proposed methods outperformed and, in some cases, performed as well
as existing methods. In most cases, we noticed some form of improvement. Detailed
simulation results under various scenarios outlined above are provided in SI: Simulation
Results and SI: Tables 5-9 (§10). Our PO model-based methods performed strongly
overall and IY P performed particularly well for lower censoring. R2CO performed similarly
to R2CH in many cases, but it is important to note that our modified version, R2ModCH ,
performed better than R2CH in most cases and similarly to it in other cases. Overall,
depending on the simulation scheme and type of non-proportional hazards present, we
can identify the benefits of utilizing each of our measures. Most importantly, the proposed
feature selection methods are more flexible and generalize existing methods.
6 Application to genomic data
In this section, we compare the performance of the proposed methods using several data
sets representing a broad spectrum of high-throughput genomic technologies. In addition
to data sets 1-5 described in §3, we utilized the following data sets. Data set 6 consists of
microarray gene expression profiles measured on the same set of glioblastoma samples
used in data sets 1 and 2, while data sets 7 and 8 consist of DNA methylation and copy
number variation profiles, respectively, from subjects with head and neck squamous cell
carcinoma. Since we do not have prior knowledge on the number of genomic features
significantly associated with survival in real data, this approach will differ from that of the
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simulations. Here, we will rank features based on each method and compare them using
a preselected number of top features across methods. Whenever possible, parameter
estimates required for computing certain I and R2 measures were obtained from respec-
tive models adjusted for potential confounders such as age and stage of disease. These
measures include IPO, R2LR, R2I˜PO , R
2
I˜PH
and the absolute effect size estimate, c′+, from
concordance regression. In addition to continuous feature expression, dichotomized ex-
pression was utilized for IPO and c′+ and no adjustment for confounders was done for
analyses involving dichotomized data in order to enable direct comparison of results to
IY P which accommodates only a single dichotomized covariate due to current limitations
in the YP model implementation (Yang & Prentice, 2005; 2012). Overall, the approach
outlined above for computing the proposed I and R2 measures parallels the analyses
presented in §3 comparing different models.
We begin by focusing attention on the application of our proposed I measures -
IPO and IY P - and c′+, selecting the top 500 features based on each measure. We observe
that there are few features commonly selected by all three measures, as evidenced in the
Venn diagrams presented in SI: Figures 1 (data sets 1, 2 and 6) and 2 (data sets 3, 7, 8,
4, and 5). This is not surprising given that these measures are based on different model
assumptions. However, it is interesting to note that in the glioblastoma data sets (1, 2 and
6) and in the HNSCC data sets 7 and 8, a large fraction of the selected features (62%,
88%, 75%, 62% and 53% respectively) are common to IPO and c′+. Overall, relatively
fewer features appear to be commonly selected by IY P and c′+. For dichotomized data, it
is evident that feature sets corresponding to different measures are much less concordant
compared to continuous expression, as shown in SI: Figure 3 (data sets 1, 2 and 4).
Using the test statistic for IˆPO developed in §4 and denoted by χˆ2PO, we computed
a p-value for each feature and selected features by controlling the FDR at 5% using the
Benjamini-Hochberg approach (Benjamini & Hochberg, 1995). It should be noted that this
approach can also be used to rank features and to compare different measures. Table
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4 summarizes the results of this analysis for continuous and dichotomized feature ex-
pression for various data sets. In almost all cases, χˆ2PO selects a much larger number of
features compared to c′+ which does not select many features at all in the first place. This
is likely due to its more general form which accounts for PH as well some form of NPH.
Although adjustment for confounding effects of age and stage or for multiple testing typ-
ically reduce the number of features significantly associated with survival, we observed
that c′+ identified fewer features even without such adjustments and fared poorly overall
compared to χˆ2PO not only in selecting features with some type of NPH but also in se-
lecting features with PH, based on statistical significance. This limitation is recognized
in Dunkler et al. (2010) and it renders c′+ as a tool for feature ranking only rather than
feature selection, unlike χˆ2PO which can both be used for ranking as well as selecting fea-
tures based on a pre-specified p-value or FDR threshold. These observations provide an
argument in favor of the use of χˆ2PO for feature selection and ranking. In SI: Application to
Genomic Data (§11) and SI: Figures 8-12, we outline an approach to evaluate and visual-
ize the combined effect of features selected on survival. We thus recommend the use of
IPO, χˆ2PO or IY P because of their inherent versatility. While IY P is able to handle various
types of hazards and retains both IPO and IPH as special cases, its performance could
be significantly improved by developing methods to estimate the YP model parameters for
continuous data which are currently unavailable. On the other hand, IPO performed better
than or at least similarly to cˆ′+ in every simulation scenario considered. All three measures
are easy to calculate and the associated statistical test can be used for simple feature se-
lection at a pre-defined significance or FDR threshold, as shown in the examples in this
section.
Next, we examine the differences between genomic features selected by various
R2 measures, once again selecting the top 500 features in each case. SI: Figure 4 shows
the overlaps between PO-based R2 measures - R2PO, R2LR, and R2I˜PO - for the glioblastoma
data sets (1, 2 and 6). Since data set 2 contained a small number of features (454), the top
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Table 4: Number of features selected by χˆ2PO and c′+
Data type Continuous Dichotomous
Data set χˆ2PO c′+ χˆ2PO c′+
1 1097 99 318 0
2 33 0 17 0
3 1,580 7 1,963 2
4 4,784 17 6,057 0
5 758 1,473 4,099 323
6 310 0 - -
7 5,799 0 3,885 21
8 464 0 64 0
50 selected features were compared. The results are, however, consistent across these
data sets where we observe a large fraction of common features selected by different
measures. In all three data sets, a large fraction of features (> 80%) are common to all
three measures as well as between any pair of measures. SI: Figure 5 shows the overlaps
between PO-based R2 measures for the HNSCC (3, 7 and 8), ovarian (4) and oral (5)
data sets where we, once again, observe a significant fraction of features common to
different measures. Overall, 55-80% of features are common to all three measures while
61-96% of features are common between to any pair of measures. These results are not
surprising since all three measures are based on the PO model and performed similarly
in the simulations.
Venn diagrams corresponding to R2PO, R2CO, and R2ModCH are shown in SI: Figures
6 (data sets 1, 2 and 6) and 7 (data sets 3, 7, 8, 4 and 5). We observe that there are only
minor overlaps between different measures across all data sets, with the largest overlaps
occurring between R2PO and R2ModCH for data sets 5 and 8 and between R
2
CO and R2ModCH
for data sets 1, 6 and 8. However, there are no features common to all three measures
in data sets 3, 4, 6, 7 and 8, and only a very small number of common features in the
remaining data sets. This is not surprising since each of these methods is based on a
different model, so we would expect them to select different features. Although not shown
here, we note that R2CH and R2ModCH selected a large proportion of common features in all
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of the data sets; however, R2ModCH provided a robust estimate compared to R
2
CH due to its
computational correction. The differences in observed selected features across the three
measures are most likely related to the presence of NPH features; for example, R2CH is
specifically designed to identify crossing hazards, but a measure based on PO or YP will
provide more flexibility as it allows for different types of time-varying hazards as well as
PH. Thus, the appropriate measure can be chosen based on the goal of feature selection
and type of hazards present or expected. We emphasize that our proposed measures
provide a more versatile and general framework that allows for inclusion of various types
of hazards.
The R2 measures can be interpreted as the percentage of separation in feature
expression between those experiencing the event of interest and those not experiencing
it. As seen in SI: Figures 6 and 7, R2PO, R2CO, and R2ModCH select fairly independent
subsets of features, and each set can be used for further exploration and study. The PO
model-based measures demonstrated their ability to handle PH and various forms of NPH
throughout the simulation results while R2ModCH only performed well in detecting crossing
hazards; moreover, R2CO offers an alternative approach to R2ModCH and is better suited for
handling particular forms of time-varying hazards. Thus, each measure provides useful
information specific to a particular model of interest while PO model-based R2 measures
provide overall flexibility relative to other measures.
7 Summary and discussion
In this paper, we proposed unified methods for feature selection in large-scale genomic
data in the presence of censored survival outcomes. We illustrated the utility of these
methods using real-life studies in cancer genomics; in particular, we demonstrated their
ability to handle the challenges due to various forms of non-proportional hazards. The
proposed methods are based on models that relax the PH assumption and are able to
identify genomic features with a time-varying effect with increased specificity and sensi-
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tivity.
Our methods are flexible and generalize existing methods for feature selection by
casting them within unifying frameworks. First, we proposed a general framework to test
for the effect of a genomic feature under the YP model using KL information divergence
by developing the measure IY P which quantifies this effect. IY P contains corresponding
measures for the PO and PH model - IPO and IPH , respectively - as special cases. An
advantage of these measures is that they do not require an estimate of the baseline
hazard and, instead, are simple functions of model parameters. Using these measures,
we developed a statistical test (χˆ2PO) for genomic feature effect in the PO model where
the test-statistic or p-value could be used for feature selection. Using IPH and IPO, we
developed R2
I˜PH
and R2
I˜PH
for the PH and PO model, respectively, that only rely on the
corresponding regression coefficient; in addition, we developed alternative R2 measures
(R2LR) based on the likelihood ratio for the PO model. All these R2 measures are easily
interpretable as the fraction of variation explained by the respective models. Finally, we
proposed a generalized pseudo-R2 measure that embeds measures for the PO, CO, PH,
and CH models as special cases. These measures do not require an estimate of the
model parameter and can be easily interpreted as the percentage of separability between
subjects in the event and non-event groups according to feature expression.
All proposed R2 measures can be applied to quantitative (continuous or ordered
categorical) data and I measures are applicable to quantitative or dichotomized data;
however, IY P is currently usable only on dichotomized data. Use of (appropriately vari-
ance stabilized and normalized) quantitative feature expression aids in robust estima-
tion of time-varying effects and interpretability while dichotomized expression facilitates
visualization of results. However, it is important to be aware of the potential effect of
dichotomization - using the median split or any other arbitrary cut-off - on the PH as-
sumption. This is evidenced by the results in Tables 1 and 2 for data sets 1 and 2 where
dichotomization has a negative and positive effect, respectively, on GOF. The proposed I
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measures are useful for feature ranking in general and, in particular, when the distribution
of feature expression or a normalizing transformation for it is unknown. Furthermore, IPO,
R2
I˜PO
, R2
I˜PH
and R2LR can accommodate potential confounders such as age and stage of
disease directly or indirectly in their computation (as illustrated in our examples) as well as
a group of pre-selected features depending on the application of interest. While IY P offers
an approach for feature ranking using a flexible survival model for dichotomized feature
expression, χˆ2PO provides a method for feature ranking as well as selection for both contin-
uous and dichotomized feature expression. Typically, it selects more features at the same
significance threshold and, thus, provides a more lenient approach for feature discovery
relative to standard methods and CON as evidenced in Table 4. Moreover, our results
demonstrate that it includes a significant fraction of features identified by CON. This is a
desirable property of any feature selection method and it enables appropriate correction
for multiple testing through use of FDR based not only on the Benjamini-Hochberg ap-
proach which assumes independent hypotheses but even a more stringent method such
as Benjamini-Yekutieli that accounts for dependence amongst hypotheses. Such flexi-
bility is not possible with currently available methods for feature selection and ranking
especially within a broad framework that includes the YP, PO and PH models.
Our extensive simulation studies demonstrated that there were a variety of scenar-
ios where our proposed measures outperformed currently available methods. An impor-
tant consideration is that when marginal screening methods are utilized for the purpose
of feature ranking and selection, the issue of multiple testing becomes less important in
comparison to adjusting for potential confounders when considering different models and
measures. The proposed methods demonstrated their ability to correctly select genomic
features associated with survival in the presence of different types of time-varying effects
in real genomic data, after adjusting for potential confounders and for multiple testing, as
well as in simulated data. As genomic technologies continue to advance and as more
clinical, demographic and genomic data are generated and stored in repositories such as
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TCGA, Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) etc., feature se-
lection methods will become increasingly important as we attempt to identify genomic
features with a prognostic impact on patient survival. Although we focused on genomic
feature selection in this paper, it should be noted that the proposed methods are directly
applicable to a broad array of high-throughput “omics” studies such as those involving
genome-wide association, proteomics, metabolomics, transcriptomics and radiomics. In
particular, radiomics is a rapidly developing area which involves a multitude of quanti-
tative measurements of tumor heterogeneity based on various imaging modalities such
as computed tomography and magnetic resonance imaging. There has been consider-
able interest recently in correlating intra-tumor heterogeneity based on textural features
to survival endpoints.
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Supplementary Information
8 Data Sets and Implementation
Data sets 1, 2 and 6
These data sets were published by TCGA (http://cancergenome.nih.gov/). Data set 1
consists of the methylation profiles (beta values) of tumor samples from 280 patients with
glioblastoma (GBM) obtained using the Infinium HumanMethylation27 platform. The beta
values were normalized using the logit transformation. For genes with multiple methy-
lation probes, the probe most negatively correlated with expression is used. Data set
2 consists of microRNA expression profiles in the form of z-scores compared to all tu-
mors for 416 patients with GBM. Data set 6 consists of merged mRNA and microRNA
z-scores from 426 patients with GBM where mRNA expression z-scores were compared
to diploid tumors (diploid for each gene) using median values from all three mRNA expres-
sion platforms (Affymetrix U133, Affymetrix Exon, and Agilent), and microRNA z-scores
were compared to all tumors. Data sets 1, 2 and 6 contain a total of 9,452, 454 and
15,546 features, respectively.
Data sets 3, 7 and 8
These data sets were published by TCGA (http://cancergenome.nih.gov/). The raw genome-
wide methylation data for ∼ 485, 000 CpG sites (based on Infinium HumanMethylation450
BeadChip Kit, Illumina, Inc.) obtained from tumor samples of 286 patients with head
and neck squamous cell carcinoma (HNSCC) were retrieved from TCGA, and M-values
(methylation signal quantified by logit-transformed beta values) were calculated for each
CpG site using the Bioconductor package Minfi (Aryee et al., 2014). CpGs located in the
transcription start sites and UTR regions for each gene were retrieved and used in further
analyses. Somatic copy number variation (CNV) - expressed in discretized form as gain
or loss (-2,-1,0,1,2) - and RNA-Seq gene expression data - presented as RSEM values (Li
& Dewey, 2011) - were obtained from the Broad Institute (http://gdac.broadinstitute.org/).
CNV data was filtered by removing genes with identical copy number variation across
subjects. RNA-seq data was normalized using the log2(x + 1) transformation. A gene
was included in the analyses only if (i) if 50% of patients have expression values for that
gene, and (ii) protein expression of that gene was observed in at least one head and neck
cancer sample in the Human Protein Atlas database (Uhlen et al., 2015). Data sets 7 and
8 consist of methylation and CNV data, respectively, for 286 patients with HNSCC while
data set 3 consists of RNA-Seq data for 221 patients with cancers of the oral cavity, a
subgroup of HNSCC. Data sets 3, 7 and 8 contain a total of 19,341, 49,270 and 5,869
features, respectively, after the above pre-processing steps.
32
https://biostats.bepress.com/cobra/art120
Data sets 4
Tothill et al. (2008) studied the relationship between recurrence-free survival and gene
expression in ovarian cancer using tumor samples from 276 subjects and Affymetrix U133
Plus 2 microarrays. This RMA normalized data set (Irizarry et al., 2003) was filtered
using a coefficient of variation threshold of 35% to remove genes with low variation in
expression and contains the expression profiles of 24,739 probe sets. In all analyses, log2
transformed data was used.
Data set 5
Saintigny et al. (2011) studied 86 subjects enrolled in a clinical chemoprevention trial
where the primary endpoint of interest was the development of oral cancer. This RMA
normalized and log2 transformed data set (Irizarry et al., 2003) contains the expression
profiles of 12,776 probe sets obtained using the Human Gene 1.ST platform.
Implementation
All computations were done using the R Statistical Language and Environment (R Core
Team, 2018) and Bioconductor (Gentleman et al., 2004). The following packages were
utilized as needed: survival, timereg, YPmodel, qvalue, Minfi, affy, concreg, gplots, VennDia-
gram and latex2exp.
9 Methods
9.1 Derivation of IY P
Under the YP model defined in equations (2.5) and (2.6) and the identities f(t|z) =
λ(t|z)S(t|z) and f0(t) = λ0(t)S0(t), feature-specific KL information divergence for this
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model has the form
IY P (F0 : F |z) =
∞∫
0
f0(t) log
{
λ0(t)S0(t)
λ(t|z)S(t|z)
}
dt
=
∞∫
0
f0(t) log
{
[exp(βz)− S0(t) exp(βz) + S0(t) exp(γz)]exp(γz)+1
exp [(β + γ)z] exp(γz)exp(γz)S0(t)exp(γz)−1
}
dt
= −(β + γ)z − γz exp(γz)− [exp(γz)− 1]
∞∫
0
f0(t) log [S0(t)] dt
+ [exp(γz) + 1]
∞∫
0
f0(t) log [exp(βz)− S0(t) exp(βz) + S0(t) exp(γz)] dt
In the second term, let u = S0(t) and du = −f0(t)dt.
In the third term, let u = exp(βz)− S0(t) exp(βz) + S0(t) exp(γz)
and du = f0(t) [exp(βz)− exp(γz)] dt
= −(β + γ)z − γz exp(γz) + [exp(γz)− 1]
0∫
1
log udu+
exp(γz) + 1
exp(βz)− exp(γz)
exp(βz)∫
exp(γz)
log udu
= −(β + γ)z − γz exp(γz) + [exp(γz)− 1]
+
exp(γz) + 1
exp(βz)− exp(γz) [βz exp(βz)− exp(βz) + exp(γz)− γz exp(γz)]
=
exp(βz) [βz exp(γz)− γz − 2]− exp(γz) [γz exp(βz)− βz − 2]
exp(βz)− exp(γz) .
Theorem 1. IˆY P is a maximum likelihood estimator and is asymptotically normal with
mean IY P .
Proof. It can be seen from equation (4.3) that IˆY P is a simple transformation of the pseudo
maximum likelihood estimators βˆ and γˆ. Since (βˆ, γˆ) is asymptotically bivariate normal
with mean (β, γ), using the invariance property of maximum likelihood estimators it can be
concluded that IˆY P is also asymptotically normal with the mean above. For more details,
see Yang & Prentice (2005) and Devarajan & Ebrahimi (2009).
9.2 Derivation of IPO and V ar(IˆPO)
IPO(F0 : F ) is obtained by setting γ = 0 in the expression for IY P (F0 : F ). It turns out
that KL information divergence is symmetric for the PO model, i.e., IPO(F0 : F ) = IPO(F :
F0) (Spirko, 2016). This measure is weighted equally towards the null and alternative
hypotheses.
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Theorem 2. IˆPO is a maximum likelihood estimator and is asymptotically normal with
mean IPO.
Proof. It can be seen from equation (4.4) that IˆPO is a simple transformation of the mod-
ified partial likelihood estimator βˆ. Since βˆ is asymptotically normal with mean β, using
the invariance property of maximum likelihood estimators it can be concluded that IˆPO is
also asymptotically normal with the mean above. For more details, see Martinussen &
Scheike (2006) and Devarajan & Ebrahimi (2009).
Using equation (4.4), for a given feature j with expression z, variance of IˆPO can be written
in terms of βˆ as (suppressing the subscript j)
Var(IˆPO) = Var
(
n∑
i=1
βˆzi − 2 + 2βˆzi
exp(βˆzi)− 1
)
=
n∑
i=1
n∑
j=1
Cov
([
βˆzi − 2 + 2βˆzi
exp(βˆzi)− 1
]
,
[
βˆzj − 2 + 2βˆzj
exp(βˆzj)− 1
])
Let I(β) denote IPO in equation (4.4) expressed as a function of the parameter β for each
observation i. Expanding I(β) using the first three terms of the Taylor series, we get
I(β) ≈ I(0) + I ′(0)β + 1
2
I ′′(0)β2 + 1
6
I ′′′(0)β3
where
I(β) = βzi − 2 + 2βziexp(βzi)−1
I ′(β) = zi +
2zi[exp(βzi)−1]−2βz2i exp(βzi)
[exp(βzi)−1]2
I ′′(β) = [
−2β′z3i exp(βzi)][exp(βzi)−1]2−2zi exp(βzi)[exp(βzi)−1][2zi[exp(βzi)−1]−2βz2i exp(βzi)]
[exp(βzi)−1]4
=
2βz3i exp(2βzi)+2βz
3
i exp(βzi)−4z2i exp(2βzi)+4z2i exp(βzi)
[exp(βzi)−1]3
I ′′′(β) = 6z
3
i exp(3βzi)−2βz4i exp(3βzi)−8βz4i exp(2βzi)−6z3i exp(βzi)−2βz4i exp(βzi)
[exp(βzi)−1]4
Taking the limit as β → 0 of all four functions above, we get
lim
β→0
I(β) = lim
β→0
I ′(β) = lim
β→0
I ′′′(β) = 0
lim
β→0
I ′′(β) = 1
3
z2i
Thus, I(β) ≈ 0 + 0 + 1
2
(1
3
z2i )β
2 + 0 = 1
6
z2i β
2
Now, using the above results the approximate variance of IˆPO can be computed as follows.
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Var(IˆPO) ≈ Cov
([
1
6
z2i βˆ
2
]
,
[
1
6
z2j βˆ
2
])
=
n∑
i=1
n∑
j=1
E
[(
1
6
z2i βˆ
2
)(
1
6
z2j βˆ
2
)]
− E
[
1
6
z2i βˆ
2
]
E
[
1
6
z2j βˆ
2
]
=
n∑
i=1
n∑
j=1
1
36
z2i z
2
jE
[
βˆ4
]
− 1
36
z2i z
2
jE
[
βˆ2
]2
=
n∑
i=1
n∑
j=1
1
36
z2i z
2
j
(
3σ4
)− 1
36
z2i z
2
j
(
σ2
)2
=
n∑
i=1
n∑
j=1
1
18
z2i z
2
jσ
4
The fourth equality above is obtained using the fact E(βˆ2k) = 2k!σ
2k
2kk!
where σ2 is the vari-
ance of βˆ under H0.
9.3 Derivation of I˜PO and I˜PH
PO model For the PO model, using equations (4.9) and (4.7),
I˜PO =
∫ ∞
−∞
IPO(z)fZ(z)dz =
∫ ∞
−∞
(βz − 2)fZ(z)dz +
∫ ∞
−∞
2βz
exp(βz)− 1fZ(z)dz
= −2 +
∫ ∞
−∞
2βz
exp(βz)− 1fZ(z)dz
= −2 + Ef [g(z)],
where g(z) = 2βz
exp(βz)−1 . Using the Taylor series expansion, we can estimate Ef [g(z)] by
Ef [g(z)] ≈ g(µz) + g′(µz)E(z − µz) + g
′′(µz)
2
E[(z − µz)2]
= g(0) +
g′′(0)
2
,
where g′′(z) = 2β
3x exp(2βx)−4β2 exp(2βx)+2β3x exp(βx)+4β2 exp(βx)
[exp(βx)−1]3 . Now, take the limz→0 for g(z) and
g′′(z) using L’Hopital’s rule to get
lim
z→0
g(z) = 2 and lim
z→0
g′′(z) = 1
3
β2.
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Thus, E[g(z)] ≈ 2 + 1
2
(1
3
β2) = 2 + 1
6
β2, and therefore,
I˜PO = −2 + 2 + 1
6
β2 =
1
6
β2. (9.1)
The R2 measure is then defined as
R2
I˜PO
= 1− exp(−2I˜PO), (9.2)
where β in I˜PO is replaced by βˆ, the modified partial likelihood estimator in the PO model
(Martinussen and Scheike 2006).
PH model For the PH model, using equations (4.8) and (4.9),
I˜PH =
∫ ∞
−∞
IPH(z)fZ(z)dz =
∫ ∞
−∞
exp(βz)fZ(z)dz +
∫ ∞
−∞
(−βz − 1)fZ(z)dz
=
[∫ ∞
−∞
exp(βz)
1√
2pi
exp
(−z2
2
)
dz
]
− 1
= exp
(
1
2
β2
)
− 1. (9.3)
R2 is defined as
R2
I˜PH
= 1− exp(−2I˜PH). (9.4)
where β in I˜PH is replaced by βˆ, the partial likelihood estimator parameter in the PH model
(Cox 1972).
9.4 Derivation of the generalized pseudo-R2 measure
Following standard counting process notation for censored survival data, let Ni(t) = {0, 1}
denote the number of events that have occurred for subject i, i = 1, · · · , n in the interval
(0, t] and let Yi(t) = 1 indicate that subject i is at risk just before time t. Here, N¯(t) =∑n
i=1 Ni(t) and Y¯ (t) =
∑n
i=1 Yi(t) denote, respectively, the total number of events that have
occurred in (0, t] and the number of subjects at risk at time t. Let β denote the parameter
and let Ui(β; t) denote the score function for individual i obtained as the derivative of the
logarithm of partial likelihood with respect to β for a particular model of interest. For each
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model, it can be shown that the score evaluated at β = 0 has the form
Ui(0; t) =
t∫
0
w∗(s)
zi −
n∑
j=1;j 6=i
Yj(s)zj
n∑
j=1
Yj(s)− 1

 dNi(s)
=
t∫
0
w(s)(Y¯ (s)− 1)Y¯ (s)
zi −
∑
j∈R∗(ti)
zj
Y¯ (s)− 1

 dNi(s), (9.5)
where w∗(s) = w(s)
(
Y¯ (s)−1
Y¯ (s)
)
, w(s) is a weight function that is model-specific, and R∗(t)
is the set of individuals not experiencing the event at time t. Thus, it can be seen that
this is a measure of the weighted difference in the expression of a genomic feature be-
tween subjects observed to experience the event of interest and those observed to not
experience the event. For each observation i, an estimate for Ui(0; t) is given by
Uˆi = δiwˆ(ti)
zi −
n∑
j=1
Yj(ti)zj
n∑
j=1
Yj(ti)
 , (9.6)
where estimation of wˆ(ti) is discussed later in this section and δi is the indicator of failure
at time ti. Following Rouam et al. (2011), we utilize the robust score proposed in Lin &
Wei (1989) given by
Wi(0; t) =
t∫
0
{
w(s)
[
zi − s
(0)(t)
s(1)(t)
]}
dNi(s), (9.7)
where s(r)(t) = E[S(r)(t)], r = 0, 1;S(0)(t) =
∑n
i=1 Yi(t) and S
(1)(t) =
∑n
i=1 Yi(t)zi. This
quantity can be estimated by
Wˆi = Uˆi−EUˆi = δiwˆ(ti)
zi −
n∑
j=1
Yj(ti)zj
n∑
j=1
Yj(ti)
− n∑
j=1
δjwˆ(tj)Yi(tj)
n∑
r=1
Yr(tj)
zi −
n∑
r=1
Yr(tj)zr
n∑
r=1
Yr(tj)
 . (9.8)
The sum of Wis is identical to the sum of Uis but Wis are independent under the PH
model. Using Wi, a pseudo-R2 index can then be written as
R2 =
1
k
(
n∑
i=1
Wˆi
)2
n∑
i=1
Wˆ 2i
, (9.9)
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where k is the number of uncensored failure times. Next, we compute U(0; t) for the PO
and CO models defined in equations (2.3) and (2.4), respectively, and use it to derive
respective weights w(t).
PO model For the PO model defined in equation (2.3), the following quantities represent
the survival and hazard functions, respectively,
S(t|z) = S0(t)
S0(t)− S0(t) exp(βz) + exp(βz) (9.10)
and
λ(t|z) = −∂ lnS(t|z)
∂t
=
λ0(t) exp(βz)
S0(t)− S0(t) exp(βz) + exp(βz) . (9.11)
Using equations (9.10) and (9.11), the partial likelihood for the PO model can be written
as
L(β) =
∏
t≤τ
n∏
i=1

λi(t|zi)
n∑
j=1
Yj(t)λj(t|zj)

∆Ni(t)
=
∏
t≤τ
n∏
i=1

λ0(t) exp(βzi)
S0(t)−S0(t) exp(βzi)+exp(βzi)
n∑
j=1
Yj(t)λ0(t) exp(βzj)
S0(t)−S0(t) exp(βzj)+exp(βzj)

∆Ni(t)
,
where Yj(t) = 1 if the subject is at risk before time t, and zi represents the expression of a
given feature for subject i. For fixed t, logL(β) =
n∑
i=1
t∫
0
{
βzi − log [S0(s)− S0(s) exp(βzi) + exp(βzi)]− log
[
n∑
j=1
Yj(s) exp(βzj)
S0(s)−S0(s) exp(βzj)+exp(βzj)
]}
dNi(s).
Hence,
U(β; t) =
d logL(β)
dβ
=
n∑
i=1
t∫
0
zi −
zi exp(βzi)[1− S0(s)]
S0(s)− S0(s) exp(βzi) + exp(βzi) −
n∑
j=1
Yj(s)zj exp(βzj)S0(s)
[S0(s)−S0(s) exp(βzj)+exp(βzj)]2
n∑
j=1
Yj(s) exp(βzj)
S0(s)−S0(s) exp(βzj)+exp(βzj)
dNi(s),
(9.12)
and setting β = 0, we get
U(0; t) =
n∑
i=1
t∫
0
ziS0(s)−
n∑
j=1
Yj(s)zjS0(s)
n∑
j=1
Yj(s)
dNi(s) =
n∑
i=1
t∫
0
w(s)
zi −
n∑
j=1
Yj(s)zj
n∑
j=1
Yj(s)

dNi(s),
(9.13)
where w(s) = S0(s).
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CO model The CO model in equation (2.4) introduces another parameter into the PO
model and has the form
1−S(t|z))
S(t|z)) =
[
1−S0(t)
S0(t)
]exp (γz)
exp(βz).
It is useful because of this generalization, and it allows the hazard functions corresponding
to two values of a covariate to cross. Here, we set γ = β such that
1−S(t|z))
S(t|z)) =
[
1−S0(t)
S0(t)
]expβz
exp(βz).
Then, the survival and hazard functions for this special case of the CO model can be
written as
S(t|z) = 1
exp(βz)
[
1−S0(t)
S0(t)
]exp(βz)
+ 1
=
S0(t)
exp(βz)
exp(βz) [1− S0(t)]exp(βz) + S0(t)exp(βz)
(9.14)
and
λ(t|z) = −∂ lnS(t|z)
∂t
=
λ0(t) exp(2βz)
[1− S0(t)]
[
exp(βz) +
(
S0(t)
1−S0(t)
)exp(βz)] , (9.15)
respectively. The partial likelihood is written as
L(β) =
∏
t≤τ
n∏
i=1

λi(t|zi)
n∑
j=1
Yj(t)λj(t|zj)

∆Ni(t)
=
∏
t≤τ
n∏
i=1

λ0(t) exp(2βzi)
[1−S0(t)]
[
exp(βzi)+
(
S0(t)
1−S0(t)
)exp(βzi)]
n∑
j=1
Yj(t)λ0(t) exp(2βzj)
[1−S0(t)]
[
exp(βzj)+
(
S0(t)
1−S0(t)
)exp(βzj)]

∆Ni(t)
,
where Yj(t) = 1 if the subject is at risk before time t. For fixed t, logL(β) =
n∑
i=1
t∫
0
{
2βzi − log [1− S0(s)]− log
[
exp(βzj) +
(
S0(s)
1−S0(s)
)exp(βzj)]
− log
[
n∑
j=1
Yj(s) exp(2βzj)
[1−S0(s)]
[
exp(βzj)+
(
S0(s)
1−S0(s)
)exp(βzj)]
]}
dNi(s) .
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Hence,
U(β; t) =
d logL(β)
dβ
=
n∑
i=1
t∫
0
{
2zi −
zi exp(βzi) + zi exp(βzi) log
(
S0(s)
1−S0(s)
)(
S0(s)
1−S0(s)
)exp(βzi)
exp(βzj) +
(
S0(s)
1−S0(s)
)exp(βzj)
−
n∑
j=1
Yj(s)zj exp(2βzj)[1−S0(s)]
{
2
(
S0(s)
1−S0(s)
)exp(βzj)−log( S0(s)
1−S0(s)
)
exp(βzj)
(
S0(s)
1−S0(s)
)exp(βzj)
+exp(βzj)
}
{
[1−S0(s)]
[
exp(βzj)+
(
S0(s)
1−S0(s)
)exp(βzj)]}2
n∑
j=1
Yj(s) exp(2βzj)
[1−S0(s)]
[
exp(βzj)+
(
S0(s)
1−S0(s)
)exp(βzj)]
}
dNi(s),
(9.16)
and setting β = 0, we get
U(0; t) =
n∑
i=1
t∫
0
{
2zi −
zi + zi log
(
S0(s)
1−S0(s)
)(
S0(s)
1−S0(s)
)
1 + S0(s)1−S0(s)
−
Yj(s)zj [1− S0(s)]
{
2
(
S0(s)
1−S0(s)
)
− log
(
S0(s)
1−S0(s)
)(
S0(s)
1−S0(s)
)
+ 1
}
n∑
j=1
Yj(s)
}
dNi(s)
=
n∑
i=1
t∫
0
zi
[
1 + S0(s)− S0(s) log
(
S0(s)
1− S0(s)
)]
−
n∑
j=1
Yj(s)zj
[
1 + S0(s)− S0(s) log
(
S0(s)
1−S0(s)
)]
n∑
j=1
Yj(s)
 dNi(s)
=
n∑
i=1
t∫
0
w(s)
zi −
n∑
j=1
Yj(s)zj
n∑
j=1
Yj(s)

dNi(s), (9.17)
where w(s) = 1 + S0(s)− S0(s) log
(
S0(s)
1−S0(s)
)
.
General Form Using equations (9.13) and (9.17), the score function can be expressed
in the following generalized form
U(0; t) =
n∑
i=1
t∫
0
w(s)
zi −
n∑
j=1
Yj(s)zj
n∑
j=1
Yj(s)

dNi(s) =
t∫
0
w(s)(Y¯ − 1)Y¯
zi −
∑
j∈R∗(ti)
zj
Y¯ − 1

dNi(s),
(9.18)
that includes the PO and CO models where w(s) is the model-specific weight function and
the other terms are as defined before. Using weights specified in Table 3 for the PH and
CH models (Rouam et al, 2010; 2011), equation (9.18) can be seen to represent the gen-
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eralized score function that includes the PH, CH, PO and CO models under consideration
in this paper.
Computational correction forR2CH andR2CO The measureR2CH has weight wˆ(ti) = (1+
log ˆΛ0(ti)), where Λ0(ti) is estimated by the left-continuous version of Nelson’s estimator.
However, this weight has an inherent numerical issue when ˆΛ0(ti) = 0. To handle this
error, Rouam et al. (2011) set wˆ(ti) = 1 if ˆΛ0(ti) = 0, implying that log( ˆΛ0(ti)) → 0 as
ˆΛ0(ti)→ 0. This is unrealistic because log( ˆΛ0(ti))→ −∞ as ˆΛ0(ti)→ 0. Thus, we propose
an empirical correction for this error that uses a plot of the cumulative hazard versus the
weight to obtain an approximation for the weight as the cumulative hazard approaches
zero. In our computations, we set wˆ(ti) equal to this approximation when ˆΛ0(ti) = 0. We
call this modified measure R2ModCH . Similarly, for R
2
CO, an empirical correction was made
to account for the numerical issue when ˆS0(ti) = 1 by obtaining a graphical approximation
for the weight as ˆS0(ti)→ 1.
10 Simulation Studies
10.1 Simulation scheme 1
First, we look at the results for scheme 1, the univariate approach. Table 5 reports the
AUCs for each method across the five models considered - LN, LL1, LL2, W1 and W2.
We note that the standard deviations of the AUCs were uniformly very small throughout
and ranged from 7X10−4 to 0.02. In Table 5, we observe several scenarios where the
proposed measures outperform existing methods.
First, we look at the performance of the three R2 measures based on the PO model
- R2PO, R2LR, and R2I˜PO . In each scenario and across all censoring schemes, these mea-
sures perform almost identically. In some instances, such as LL2 under 0% and 33%
censoring, we do observe a slight improvement in R2
I˜PO
. Next, we consider PH model-
based measures - the newly proposed R2
I˜PH
and the existing R2PH . From Table 5, we
observe that the AUCs are almost identical for these measures, with a slight improvement
noted in some cases for R2
I˜PH
. In fact, based on the Youden indices in Table 7, we note
that the proposed R2
I˜PH
outperforms R2PH for all three censoring proportions for LL2 and
for the 0% censoring case for LN; this also holds true for AUCs.
Next, we examine the LN case where we observe from Table 5 that R2PH and
cˆ′+ are outperformed by various measures under different scenarios. Specifically, R2CH
and R2ModCH perform similarly and outperform PO and PH model-based R
2 measures,
except for the 67% censoring case where R2PO, R2LR, and R2I˜PO perform the best. This
is not surprising since the LN model allows for crossing hazards. R2CO performs well for
lower censoring proportions, but its AUC decreases as censoring increases. As censoring
increases, PO model-based R2 measures also outperform PH model-based measures in
terms of AUCs as well as Youden indices shown in Table 7. IY P outperforms IPO and cˆ′+
when the censoring proportion is 0 and 33% but its performance decreases as censoring
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increases. It should be noted that IY P can only be applied to dichotomized genomic data;
thus, IY P ’s performance may be affected by its inability to accommodate continuous data.
IPO also outperforms cˆ′+ as censoring increases which is also evidenced by the Youden
indices in Table 7.
Under LL1, we expect PO model-based measures to perform well since the log-
logistic model is related to the PO model, and our results provide evidence in support.
While R2CH and R2ModCH do improve as censoring increases, R
2
PO, R2LR, and R2I˜PO still
outperform R2CH and R2ModCH at each censoring level. Similar to the LN case, the per-
formance of R2CO and IY P decreases as censoring increases. Under LL2, R2PH and R2I˜PH
perform significantly worse than other R2 measures, but their AUCs do increase from ap-
proximately .50 − .54 in the 0% censoring case to .78 in the 67% censoring case. Thus,
while these measures show improved performance with higher censoring, they are still
consistently outperformed by other model-based measures. This is also evident from Ta-
ble 7, where R2PH and R2I˜PH have the lowest Youden index of all the reported measures
with the exception of R2CO under 67% censoring. The log-logistic model of LL2 allows for
crossing hazards and is related to the CO model and, not surprisingly, R2CO outperforms
PO model-based R2 measures in the 0 and 33% censoring cases but, similar to the LN
and LL1 models, we see its AUCs drop for 67% censoring. cˆ′+ is outperformed by IPO
and/or IY P , as well as by R2CO, at each censoring level, with IY P performing better for
lower censoring proportion and IPO performing better for higher censoring proportion. In
this case, we also observe that PO model-based R2 measures outperform PH model-
based methods which emphasizes the PO model’s ability to handle some forms of NPH.
These observations are further supported by the Youden indices shown in Table 7.
Under the W1 model, we observe that R2PO, R2LR, and R2I˜PO outperform R
2
CH and
R2ModCH at all censoring levels. This result is intuitive because this Weibull model is related
to the PH model and the PO model does allow for PH. Under the W2 model, we observe
that R2CO outperforms R2CH and R2ModCH at all censoring levels, especially for higher cen-
soring proportions where the improvement in performance is markedly higher. Further-
more, PO model-based measures outperform R2CH . The W2 model allows for crossing
hazards, and yet here, we observe a clear advantage for our PO and CO model-based
measures over R2CH which was purposefully designed to handle crossing hazards. Also,
in this case we observe that R2ModCH , the proposed modification to R
2
CH , performs signifi-
cantly better than R2CH as the censoring proportion increases. Youden indices for models
W1, W2, and LL1 under scheme 1 are listed in Table 8 and support the results in Table 5.
10.2 Simulation scheme 2
Next, we consider results from simulation scheme 2 which are shown in Table 6. In
general, AUCs are observed to be slightly lower than those in Table 5, but this is likely
due to the complexity of the scheme itself where correlations are introduced between
features. The observed trend in these results, however, mimic what was observed for
scheme 1. We note that the standard deviations of AUCs were very small for this scheme
as well, ranging from 7X10−4 to 0.02.
Similar to scheme 1, PO model-based R2 measures - R2PO, R2LR, and R2I˜PO - per-
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form almost identically across all scenarios and censoring levels. The PH model-based
measures - R2
I˜PH
and R2PH - also perform similarly. Under the LN model which allows for
crossing hazards, R2PH and R2I˜PH are outperformed by the proposed PO model-based R
2
measures as well as by R2CH and R2ModCH for 0 and 33% censoring cases, but for 67%
censoring the PO model-based measures perform similarly and better than the other R2
measures. The AUCs for R2CO, R2CH , and R2ModCH decrease as censoring increases, with
PO model-based measures having a clear advantage for all censoring proportions. cˆ′+ is
also outperformed by IPO and IY P for 0% and 33% censoring and by IPO for 67% censor-
ing. These differences are supported by the Youden indices shown in Table 7. Under the
LL1 model, PO and PH model-based R2 measures perform similarly and result in slightly
higher AUCs than R2CH and R2ModCH . This result is also intuitive since the log-logistic
model is related to the PO model which allows for both proportional hazards as well as
some forms of non-proportional hazards. They also significantly outperform R2CO at each
censoring level. IPO and cˆ′+ perform similarly and outperform IY P , whose AUC decreases
as censoring increases. Under the LL2 model, which allows for crossing hazards, R2CO
performs similarly to R2CH and R2ModCH and they all significantly outperform PO and PH
model-based R2 measures. This result is expected since the LL2 model allows for cross-
ing hazards. However, similar to scheme 1, R2CO’s performance falls in the 67% censoring
case. We also observe that the performance of cˆ′+ is poor and no better than a coin toss
across all censoring proportions. IY P outperforms IPO in the 0 and 33% censoring cases,
but consistent with previous results, its AUC drops in the 67% censoring case. This is fur-
ther corroborated by the Youden indices shown in Table 7 where IPO is the best performer
under 67% censoring. However, as alluded to earlier its performance may be affected by
its inability to accommodate continuous genomic data. Under the W1 model, we observe
results similar to that of scheme 1. R2PO, R2LR, and R2I˜PO outperform R
2
CH and R2ModCH at
all censoring levels which is intuitive since the PO model can accommodate proportional
hazards and the Weibull model is related to the PH model. Under W2, R2CO once again
outperforms R2CH and R2ModCH at all censoring levels and particularly for higher censor-
ing where the improvement in performance is marked; in this case, we also observe that
R2ModCH performs slightly better than R
2
CH across all censoring proportions. Youden in-
dices for models W1, W2, and LL1 under scheme 2 are listed in Table 9 and support the
results in Table 6.
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Table 5: Simulation scheme 1: Comparison of methods (AUC)
Censoring Measure LN LL1 LL2 W1 W2
IPO 0.81 1.00 0.74 1.00 1.00
IY P 1.00 0.96 0.81 1.00 1.00
cˆ′+ 0.81 1.00 0.73 1.00 1.00
R2PO 0.81 1.00 0.73 1.00 1.00
R2LR 0.81 1.00 0.73 1.00 1.00
0% R2
I˜PO
0.81 1.00 0.75 1.00 1.00
R2CO 0.99 0.86 0.84 0.93 1.00
R2CH 1.00 0.68 0.87 0.65 0.98
R2ModCH 1.00 0.73 0.89 0.69 0.98
R2
I˜PH
0.92 0.99 0.54 1.00 1.00
R2PH 0.87 0.99 0.50 1.00 1.00
IPO 0.89 0.99 0.77 0.99 1.00
IY P 0.96 0.89 0.75 0.98 1.00
cˆ′+ 0.82 0.99 0.71 0.99 1.00
R2PO 0.89 0.99 0.77 0.99 0.99
R2LR 0.88 0.99 0.77 1.00 1.00
33% R2
I˜PO
0.88 0.99 0.78 1.00 1.00
R2CO 0.82 0.69 0.80 0.82 0.87
R2CH 0.98 0.82 0.86 0.70 0.76
R2ModCH 0.97 0.84 0.87 0.74 0.82
R2
I˜PH
0.77 0.99 0.64 1.00 1.00
R2PH 0.77 0.99 0.61 1.00 1.00
IPO 0.93 0.98 0.81 0.99 0.95
IY P 0.83 0.70 0.58 0.81 0.93
cˆ′+ 0.88 0.96 0.71 0.98 0.98
R2PO 0.93 0.97 0.81 0.99 0.95
R2LR 0.93 0.98 0.81 0.99 0.95
67% R2
I˜PO
0.93 0.98 0.81 0.99 0.95
R2CO 0.68 0.63 0.74 0.51 0.89
R2CH 0.88 0.90 0.83 0.87 0.57
R2ModCH 0.87 0.90 0.84 0.87 0.71
R2
I˜PH
0.92 0.98 0.78 0.99 0.97
R2PH 0.92 0.97 0.78 0.99 0.97
11 Application to Genomic Data
Once a subset of genomic features has been selected at a particular threshold, the com-
bined effect of these features on survival can be evaluated using a weighted average
of feature expression. Let m be the number of features in a given subset of interest.
If β = {β1, . . . , βm}′ and Z are the corresponding regression coefficient vector and the
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Table 6: Simulation scheme 2: Comparison of methods (AUC)
Censoring Measure LN LL1 LL2 W1 W2
IPO 0.84 0.91 0.54 0.91 0.90
IY P 0.86 0.89 0.77 0.89 0.89
cˆ′+ 0.82 0.91 0.50 0.91 0.90
R2PO 0.84 0.91 0.55 0.91 0.90
R2LR 0.84 0.91 0.56 0.91 0.90
0% R2
I˜PO
0.82 0.91 0.57 0.91 0.90
R2CO 0.76 0.51 0.88 0.51 0.88
R2CH 0.89 0.86 0.89 0.86 0.79
R2ModCH 0.89 0.87 0.89 0.86 0.81
R2
I˜PH
0.55 0.91 0.63 0.91 0.90
R2PH 0.55 0.90 0.66 0.91 0.89
IPO 0.87 0.91 0.62 0.91 0.90
IY P 0.84 0.85 0.82 0.88 0.86
cˆ′+ 0.80 0.91 0.50 0.91 0.90
R2PO 0.87 0.90 0.63 0.90 0.89
R2LR 0.88 0.91 0.61 0.91 0.90
33% R2
I˜PO
0.86 0.91 0.64 0.91 0.90
R2CO 0.59 0.51 0.87 0.53 0.88
R2CH 0.89 0.87 0.90 0.87 0.70
R2ModCH 0.88 0.87 0.89 0.87 0.74
R2
I˜PH
0.72 0.90 0.57 0.90 0.90
R2PH 0.75 0.90 0.54 0.90 0.89
IPO 0.89 0.90 0.80 0.90 0.86
IY P 0.69 0.65 0.68 0.69 0.68
cˆ′+ 0.84 0.90 0.53 0.90 0.87
R2PO 0.89 0.90 0.81 0.90 0.84
R2LR 0.89 0.90 0.80 0.90 0.89
67% R2
I˜PO
0.88 0.90 0.80 0.90 0.89
R2CO 0.56 0.50 0.71 0.50 0.87
R2CH 0.81 0.88 0.88 0.88 0.53
R2ModCH 0.81 0.88 0.87 0.88 0.55
R2
I˜PH
0.87 0.90 0.70 0.90 0.89
R2PH 0.89 0.90 0.71 0.90 0.87
n ×m expression matrix for features in this subset, then a weighted average, η, can be
calculated as η = Zβ. Thus, η is a vector of size n, where each subject has a weighted
average computed across all m features in a subset. This weighted average uses every
feature in each subset where each features’s contribution is quantified by the estimate of
the coefficient. It is worth noting that the linear predictor η can be interpreted as the log-
arithm of the hazard ratio for the PH model and as the logarithm of the odds ratio for the
PO model. A graphical analysis of the combined effect of features selected using χˆ2PO (as
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Table 7: Simulation schemes 1 & 2: Comparison of methods (Youden Index)
Scheme 1 2
Censoring 0% 33% 67% 0% 33% 67%
Measure LN LL2 LN LL2 LN LL2 LN LL2 LN LL2 LN LL2
IPO 0.53 0.34 0.61 0.42 0.68 0.50 0.23 0.03 0.24 0.09 0.26 0.24
IY P 0.99 0.49 0.49 0.22 0.38 0.00 0.22 0.17 0.12 0.16 0.07 0.04
cˆ′+ 0.53 0.33 0.54 0.28 0.61 0.29 0.21 0.02 0.19 0.00 0.22 0.01
R2PO 0.53 0.31 0.62 0.39 0.68 0.48 0.23 0.04 0.25 0.10 0.26 0.24
R2LR 0.53 0.33 0.60 0.41 0.68 0.49 0.23 0.05 0.25 0.07 0.26 0.22
R2
I˜PO
0.52 0.36 0.59 0.43 0.68 0.50 0.20 0.06 0.23 0.11 0.25 0.19
R2CO 0.89 0.53 0.41 0.43 0.24 0.26 0.17 0.23 0.06 0.22 0.07 0.14
R2CH 0.99 0.59 0.82 0.56 0.60 0.52 0.26 0.28 0.25 0.28 0.23 0.28
R2ModCH 0.99 0.61 0.80 0.58 0.60 0.54 0.26 0.28 0.24 0.28 0.23 0.28
R2
I˜PH
0.66 0.04 0.49 0.18 0.66 0.44 0.02 0.06 0.13 0.03 0.24 0.13
R2PH 0.46 0 0.49 0.12 0.66 0.41 0.04 0.09 0.17 0.02 0.25 0.16
shown in Table 4) was performed for representative data sets from different data types.
This included data sets 1 (methylation), 2 (microRNA expression), 3 (RNA sequencing),
4 (mRNA expression) and 8 (CNV). Panels (a), (b) and (c) in Figures 8-12 represent KM
survival curves, cumulative hazard curves (on the log-scale) and odds curves, respec-
tively, for subjects with high and low weighted average feature expression (determined
by the median split) for each of these data sets. We observed that when χˆ2PO was used
to select features, the PO model generally provided a good fit while the PH did not fit in
some cases (as seen in panels (a), (b) and (c) of Figures 8-12). These observations were
further corroborated by GOF tests for the PH, PO and YP models where the PO and YP
models were found to provide a good fit for weighted feature expression in all cases. This
analysis emphasizes the versatility and modeling flexibility provided by the PO and YP
models in allowing PH as well as certain forms of NPH.
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Figure 1: Top selected genes, I measures and cˆ′+, Glioblastoma data sets
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Table 8: Simulation Scheme 1: Comparison of methods (Youden Index)
Censoring 0% 33% 67%
Measure LL1 W1 W2 LL1 W1 W2 LL1 W1 W2
IPO 0.92 0.95 0.98 0.88 0.92 0.92 0.80 0.85 0.72
IY P 0.73 0.92 0.98 0.41 0.73 0.86 0.16 0.34 0.70
cˆ′+ 0.92 0.95 0.97 0.87 0.93 0.94 0.76 0.84 0.81
R2PO 0.92 0.94 0.97 0.87 0.92 0.91 0.80 0.85 0.72
R2LR 0.92 0.98 0.97 0.88 0.95 0.92 0.81 0.86 0.73
R2
I˜PO
0.92 0.98 0.98 0.88 0.95 0.92 0.81 0.86 0.73
R2CO 0.48 0.63 0.99 0.22 0.48 0.61 0.15 0.05 0.64
R2CH 0.19 0.14 0.80 0.49 0.25 0.32 0.63 0.58 0.10
R2ModCH 0.27 0.22 0.80 0.52 0.31 0.44 0.63 0.59 0.30
R2
I˜PH
0.88 0.99 1.00 0.87 0.97 0.98 0.81 0.87 0.80
R2PH 0.87 0.96 1.00 0.85 0.94 0.97 0.79 0.86 0.79
Table 9: Simulation Scheme 2: Comparison of methods (Youden Index)
Scheme 2
Censoring 0% 33% 67%
Measure LL1 W1 W2 LL1 W1 W2 LL1 W1 W2
IPO 0.32 0.33 0.30 0.31 0.31 0.29 0.29 0.29 0.26
IY P 0.26 0.26 0.27 0.12 0.20 0.20 0.02 0.01 0.08
cˆ′+ 0.32 0.33 0.29 0.31 0.30 0.28 0.27 0.28 0.25
R2PO 0.31 0.31 0.27 0.29 0.29 0.27 0.26 0.27 0.24
R2LR 0.33 0.33 0.29 0.31 0.31 0.27 0.28 0.28 0.25
R2
I˜PO
0.32 0.32 0.30 0.31 0.30 0.27 0.28 0.28 0.25
R2CO 0.02 0.02 0.21 0.01 0.01 0.21 0.00 0.01 0.21
R2CH 0.16 0.15 0.16 0.16 0.16 0.10 0.19 0.20 0.01
R2ModCH 0.16 0.15 0.17 0.17 0.17 0.11 0.20 0.20 0.01
R2
I˜PH
0.30 0.31 0.30 0.29 0.29 0.27 0.27 0.27 0.25
R2PH 0.30 0.31 0.25 0.30 0.29 0.26 0.27 0.28 0.25
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Figure 2: Top selected genes, I measures and cˆ′+, HNSCC (3, 7, and 8), ovarian (4) and
oral (5) data sets
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Figure 3: Top selected genes, Dichotomized feature expression, Data sets 1, 2 and 4
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Figure 4: Top selected genes, PO-based R2 measures, Glioblastoma data sets
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Figure 5: Top selected genes, PO-based R2 measures, HNSCC (3, 7, and 8), ovarian (4)
and oral (5) data sets
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Figure 6: Top selected genes, Other R2 measures, Glioblastoma data sets
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Figure 7: Top selected genes, Other R2 measures, HNSCC (3, 7, and 8), ovarian (4) and
oral (5) data sets
51
Hosted by The Berkeley Electronic Press
0 20 40 60 80 100 120
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Time
Su
rv
iva
l P
ro
ba
bi
lity
Low Score
High Score
PH, PO, YP fit
PO significant
(a)
0 20 40 60 80 100 120
−
5
−
4
−
3
−
2
−
1
0
1
Time
lo
g(−
log
(S
(t)
))
Low Score
High Score
(b)
0 20 40 60 80 100 120
0
10
20
30
40
50
60
Time
O
dd
s
Low Score
High Score
(c)
Figure 8: (a) Kaplan-Meier survival curves, (b) Cumulative hazard curves (log-scale), (c)
Odds curves. Weighted expression of features selected by χ2PO for data set 1
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Figure 9: (a) Kaplan-Meier survival curves, (b) Cumulative hazard curves (log-scale), (c)
Odds curves. Weighted expression of features selected by χ2PO for data set 2
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Figure 10: (a) Kaplan-Meier survival curves, (b) Cumulative hazard curves (log-scale),
(c) Odds curves. Weighted expression of features selected by χ2PO for data set 3
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Figure 11: (a) Kaplan-Meier survival curves, (b) Cumulative hazard curves (log-scale),
(c) Odds curves. Weighted expression of features selected by χ2PO for data set 4
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Figure 12: (a) Kaplan-Meier survival curves, (b) Cumulative hazard curves (log-scale),
(c) Odds curves. Weighted expression of features selected by χ2PO for data set 8
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